(NASDAQ: CLNN) Clene's forecast annual revenue growth rate of 639.44% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 85.29%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.87%.
Clene's revenue in 2025 is $286,000.On average, 2 Wall Street analysts forecast CLNN's revenue for 2025 to be $3,047,123, with the lowest CLNN revenue forecast at $2,997,170, and the highest CLNN revenue forecast at $3,097,076. On average, 2 Wall Street analysts forecast CLNN's revenue for 2026 to be $64,938,692, with the lowest CLNN revenue forecast at $3,996,227, and the highest CLNN revenue forecast at $125,881,157.
In 2027, CLNN is forecast to generate $1,360,915,173 in revenue, with the lowest revenue forecast at $818,227,519 and the highest revenue forecast at $1,903,602,827.